IntelliPharmaCeutics International Inc (NASDAQ:IPCI)

Data as of 2:28pm ET
 -0.0499 / -1.62%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Intellipharmaceutics International, Inc. is a pharmaceutical company, which specializes in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of existing and new pharmaceuticals in the areas of neurology, cardiovascular, gastrointestinal tract, diabetes and pain. The company was founded on October 22, 2009 and is headquartered in Toronto, Canada.

Contact Information

Intellipharmaceutics International, Inc.
30 Worcester Road
Toronto Ontario M9W 5X2
P:(416) 798-3001
Investor Relations:



Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Isa OdidiChairman, CEO & Co-Chief Scientific Officer
Amina OdidiPresident, Chief Operating Officer & Director
Shameze RampertabCFO, VP-Finance & Head-Investor Relations
John N. AllportSecretary, Director, VP-Legal Affairs & Licensing
Patrick N. YatVice President-Chemistry & Analytical Services

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.